A brief video to summarise the results of COVIC-19 trial

Support-e project has officially concluded. It involved 12 partners, from 8 european countries, and it was funded by the European Commission. Its objective was to support an high quality evaluation of the Covid-19 Convalescent Plasma (CCP) through extensive clinical trials and to find its best therapeutic use. In the last phase of the project, Support-e Team conducted a clinical trial known as COVIC-19, with the aim of evaluating, according to the highest scientific standards, the safety and efficacy of COVID-19 convalescent plasma. Through this video, we present the results, which have contributed to the development of recommendations for the treatment of COVID-19 and for future pandemics.